cefoperazone has been researched along with Infections, Salmonella in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chaurasia, DK; Katara, P; Kesharwani, A | 1 |
| Apisarnthanarak, A; Khawcharoenporn, T; Kiratisin, P; Mundy, LM | 1 |
| Bakici, MZ; Gökalp, AS; Kaya, R; Toksoy, HB; Türkay, S | 1 |
1 review(s) available for cefoperazone and Infections, Salmonella
| Article | Year |
|---|---|
Salmonella group C necrotizing fasciitis: a case report and review of the literature.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefoperazone; Child, Preschool; Combined Modality Therapy; Diagnosis, Differential; Fasciitis, Necrotizing; Female; Humans; Lupus Erythematosus, Systemic; Male; Risk Factors; Salmonella; Salmonella Infections; Sulbactam | 2006 |
1 trial(s) available for cefoperazone and Infections, Salmonella
| Article | Year |
|---|---|
Intravenous immunoglobulin in the treatment of Salmonella typhimurium infections in preterm neonates.
Topics: Cefoperazone; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Salmonella Infections; Salmonella typhimurium | 1994 |
1 other study(ies) available for cefoperazone and Infections, Salmonella
| Article | Year |
|---|---|
Repurposing of FDA approved drugs and their validation against potential drug targets for
Topics: Cefoperazone; Drug Repositioning; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Salmonella enterica; Salmonella Infections | 2022 |